
Coartem (artemether-lumefantrine) Baby, or Riamet, has been approved by Swissmedic as the first malaria medicine for newborns and young infants. …

Pharmafocus spoke to Dr Harald Nusser, Head of Novartis Social Business, and David Reddy, CEO of Medicines for Malaria Venture …

Merck Serono and Medicines for Malaria Venture (MMV) have signed an agreement which will see them advance the development of …
Sanofi-Aventis has signed a research deal with the Medicines for Malaria Venture charity. They will work together to identify, characterise …

